Outlook Therapeutics annual capital expenditures (capex)
2015
2016
2017
2018
2019
Outlook Therapeutics Capital Expenditures (CapEx) Growth & History (OTLK)
Outlook Therapeutics's capital expenditures (capex) was $437,307 for fiscal 2019.
View full Outlook Therapeutics company overviewOutlook Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-09-30 | $437,307 | −$2.3M | −84.28% |
| 2018 | 2018-09-30 | $2.8M | $2.5M | +852.16% |
| 2017 | 2017-09-30 | $292,086 | −$806,094 | −73.40% |
| 2016 | 2016-09-30 | $1.1M | −$7.7M | −87.53% |
| 2015 | 2015-09-30 | $8.8M | — | — |
Outlook Therapeutics quarterly capital expenditures (capex)
Q3.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2019 | 2019-09-30 | $1 | −$1.3M | −100.00% |
| Q3 2019 | 2019-06-30 | $150,737 | −$17,283 | −10.29% |
| Q2 2019 | 2019-03-31 | $50,136 | −$225,050 | −81.78% |
| Q1 2019 | 2018-12-31 | $236,433 | −$838,710 | −78.01% |
| Q4 2018 | 2018-09-30 | $1.3M | $1.2M | +5165.95% |
| Q3 2018 | 2018-06-30 | $168,020 | $91,791 | +120.41% |
| Q2 2018 | 2018-03-31 | $275,186 | $231,671 | +532.39% |
| Q1 2018 | 2017-12-31 | $1.1M | $926,781 | +624.68% |
| Q4 2017 | 2017-09-30 | $23,980 | −$304,431 | −92.70% |
| Q3 2017 | 2017-06-30 | $76,229 | −$376,247 | −83.15% |
| Q2 2017 | 2017-03-31 | $43,515 | −$3,434 | −7.31% |
| Q1 2017 | 2016-12-31 | $148,362 | −$215,880 | −59.27% |
| Q4 2016 | 2016-09-30 | $328,411 | — | — |
| Q3 2016 | 2016-06-30 | $452,476 | −$3.0M | −87.03% |
| Q2 2016 | 2016-03-31 | $46,949 | — | — |
| Q1 2016 | 2015-12-31 | $364,242 | — | — |
| Q3 2015 | 2015-06-30 | $3.5M | — | — |
Outlook Therapeutics capital expenditures (capex) trends
Between the periods ended 2015-09-30 and 2019-09-30, Outlook Therapeutics's capital expenditures (capex) decreased from $8.8M to $437,307, a change of −$8.4M. The latest reported quarter, Q4 2019, shows $1.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Outlook Therapeutics source filings ↗